Products
BioEngine has developed nearly 100 types of serum-free media for different cell lines, which are suitable for antibodies, vaccines and cell and gene therapy (CGT) fields.
Time:Mar 30,2020
On March 29, 2020, Tan Wensong, chairman of Shanghai BioEngine Sci-Tech Co., Ltd., and Zhu Shaorong, chairman of Shanghai Rongsheng Biotech Co., Ltd, signed a strategic cooperation agreement at Shanghai Rongsheng Biotech Co., Ltd. Both parties will cooperate to jointly promote the application of animal cell mass culture technology in the development and efficient industrial production of human virus vaccine products.
We have a professional technical team to provide high quality one-stop cell culture service from process development
and optimization, medium formulation design to medium processing and manufacturing for all biopharmaceutical companies.
If you have any question, please click "Quick Message" and leave your message, we will reply to you as soon as possible.
If anything urgent, please call (86)21-68582660-2792.
3F&4F, Building 3, Lane 396, Lvzhou Ring Road, Minhang District, Shanghai, PRC